Arylsulfatase B regulates interaction of chondroitin-4-sulfate and kininogen in renal epithelial cells

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 5, 2010, Pages 472-477

  Bhattacharyya, Sumit ^a,b   Kotlo, Kumar ^a,b   Danziger, Robert ^a,b   Tobacman, Joanne K ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

Arylsulfatase B; Bradykinin; Chondroitin 4 sulfate; Glycosaminoglycan; Hypertension; Kininogen; Sulfate

Indexed keywords

BRADYKININ; CHLORIDE ION; CHONDROITIN 4 SULFATE; GLYCOSAMINOGLYCAN POLYSULFATE; KININOGEN; N ACETYLGALACTOSAMINE 4 SULFATASE; PHOSPHATE;

ANIMAL CELL; ARTICLE; BLOOD PRESSURE REGULATION; CELL LYSATE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME REGULATION; EPITHELIUM CELL; GENE OVEREXPRESSION; GENE SILENCING; KIDNEY EPITHELIUM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; SULFATION;

ANIMALS; BRADYKININ; CELLS, CULTURED; CHONDROITIN SULFATES; EPITHELIAL CELLS; GLYCOSAMINOGLYCANS; IMMUNOPRECIPITATION; KIDNEY; KININOGENS; N-ACETYLGALACTOSAMINE-4-SULFATASE; RATS; RNA, SMALL INTERFERING; VASODILATOR AGENTS;

RATTUS;

EID: 77950461783     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.01.014     Document Type: Article

References (21)

1. Bhattacharyya S., Tobacman J.K. Steroid sulfatase, arylsulfatases A and B, galactose 6-sulfatase, and iduronate sulfatase in mammary cells and effects of sulfated and non-sulfated estrogens on sulfatase activity. J. Steroid Biochem. Mol. Biol. 2007, 103:20-34.
2. Bhattacharyya S., Tobacman J.K. Arylsulfatase B regulates colonic epithelial cell migration by effects on MMP9 expression and RhoA activation. Clin. Exp. Metastasis 2009, 26(6):535-545.
3. Bhattacharyya S., Tobacman J.K. Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR. Clin. Chim. Acta 2007, 380:122-127.
4. Ferrero G.B., Pagliardini S., Veljkovic A., Porta F., Bena C., Tardivo I., Restagno G., Silengo M.C., Bignamini E. In vivo specific reduction of arylsulfatase B enzymatic activity in children with cystic fibrosis. Mol. Gen. Metab. 2008, 94:139.
5. Bhattacharyya S., Kotlo K., Shukla S., Danziger R.S., Tobacman J.K. Distinct effects of N-acetylgalactosamine-4-sulfatase and galactose-6-sulfatase expression on chondroitin sulfate. J. Biol. Chem. 2008, 283:9523-9530.
6. Bhattacharyya S., Solakyildirim K., Zhang Z., Linhardt R.J., Tobacman J.K. Cell-bound IL-8 increases in bronchial epithelial cells following arylsulfatase B silencing. Am. J. Respir. Cell. Mol. Biol. 2010, 42(1):51-61.
7. Wang H., Katagiri Y., McCann T.E., Unsworth E., Goldsmith P., Yu Z.X., Tan F., Santiago L., Mills E.M., Wang Y., Symes A.J., Geller H.M. Chondroitin-4-sulfation negatively regulates axonal guidance and growth. J. Cell Sci. 2008, 121:3083-3091.
8. Bhattacharrya S., Solakyildirim K., Zhang Z., Linhardt R.J., Tobacman J.K. Chloroquine reduces arylsulfatase B activity and increases chondroitin 4-sulfate: implications for mechanisms of action and resistance. Malaria J. Dec 17 2009, 8(1):303. [Electronic publication ahead of print].
9. Mitsunaga-Nakatsubo K., Kusunoki S., Kawakami H., Akasaka K., Akimoto Y. Cell-surface arylsulfatase A and B on sinusoidal endothelial cells, hepatocytes, and Kupffer cells in mammalian livers. Med. Mol. Morphol. 2009, 42:63-69.
10. Blossom D.B., Kallen A.J., Patel P.R., Elward A., Robinson L., Gao G., Langer R., Perkins K.M., Jaeger J.L., Kurkjian K.M., Jones M., Schillie S.F., Shehab N., Ketterer D., Venkataraman G., Kishimoto T.K., Shriver Z., McMahon A.W., Austen K.F., Kozlowski S., Srinivasan A., Turabelidze G., Gould C.V., Arduino M.J., Sasisekharan R. Outbreak of adverse reactions associated with contaminated heparin. N. Engl. J. Med. 2008, 359:2674-2684.
11. Kishimoto T.K., Viswanathan K., Ganguly T., Elankumaran S., Smith S., Pelzer K., Lansing J.C., Sriranganathan N., Zhao G., Galcheva-Gargova Z., Al-Hakim A., Bailey G.S., Fraser B., Roy S., Rogers-Cotrone T., Buhse L., Whary M., Fox J., Nasr M., Dal Pan G.J., Shriver Z., Langer R.S., Venkataraman G., Austen K.F., Woodcock J., Sasisekharan R. Contaminated heparin associated with adverse clinical events and activation of the contact system. N. Engl. J. Med. 2008, 358:257-2467.
12. Guerrini M., Beccati D., Shriver Z., Naggi A., Viswanathan K., Bisio A., Capila I., Lansing J.C., Guglieri S., Fraser B., Al-Hakim A., Gunay N.S., Zhang Z., Robinson L., Bushe L., Nasr M., Woodcock J., Langer R., Venkataraman G., Linhardt R.J., Casu B., Torri G., Sasisekharan R. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat. Biotechnol. 2008, 26:669-675.
13. Bairston S., McKee J., Nordhaus M., Johnson R. Identification of a simple and sensitive microplate method for the detection of oversulfated chondroitin sulfate in heparin products. Anal. Biochem. 2009, 388:317-321.
14. Renné T., Schuh K., Müller-Esterl W. Local bradykinin formation is controlled by glycosaminoglycans. J. Immunol. 2005, 175:3377-3385.
15. Gozzo A.J., Nunes V.A., Carmona A.K., Nader H.B., von Dietrich C.P., Silveira V.L.F., Shimamoto K., Ura N., Sampaio M.U., Sampaio C.A.M., Araújo M.S. Glycosaminoglycans affect the action of human plasma kallikrein on kininogen hydrolysis and inflammation. Int. Immunopharmacol. 2002, 2:1861-1865.
16. Wòjczyk B. Lysosomal arylsulfatases A and B from horse blood leukocytes: purification and physico-chemical properties. Biol. Cell 1986, 57:147-152.
17. Rao G.J., Christe M.E. Inhibition of rabbit liver arylsulfatase B by phosphate esters. Biochim. Biophys. Acta 1984, 788(1):58-61.
18. http://rgd.mcw.edu/plf/plfRGD/8/11/2009. Rat Genome Database.
19. Li B., Suwan J., Martin J.G., Zhang F., Zhang Z., Hoppensteadt D., Clark M., Fareed J., Linhardt R.J. Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins. Biochem. Pharmacol. 2009, 78:292-300.
20. Bond C.S., Clements P.R., Ashby S.J., Collyer C.A., Harrop S.J., Hopwood J.J., Guss J.M. Structure of a human lysosomal sulfatase. Structure 1997, 5:277-289.
21. Lukatela G., Krauss N., Theis K.K., Selmer T., Gieselmann V., von Figura K., Saenger W. Crystal structure of human arylsulfatase A: the aldehyde function and the metal ion at the active site suggest a novel mechanism for sulfate ester hydrolysis. Biochemistry 1998, 37:3654-3664.